Revenue surged 30% as longevity fund inflows topped $544 million.

Abacus Global Management, Inc. (ABX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Abacus Global Management, Inc. (ABX) delivered earnings and revenue surprises of +12.00% and +11.68%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

TFS Financial (TFSL) delivered earnings and revenue surprises of +37.50% and +2.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Most Americans don’t have the luxury of over-saving, but those who work with advisors might find themselves in that position if they follow financial projections that extend to an age they’re unlikely to reach. You could adjust your Social Security claiming strategy, make tweaks to your portfolio, and create a legacy plan that meets your bequest goals. “Financial planning is going to shift in a massive way to include your health and life span,” says Abacus CEO Jay Jackson.

Abacus Global Management (ABX) has drawn attention after announcing the effectiveness of the registration statement for its ABX Longevity Growth and Income Fund, an interval fund focused primarily on longevity assets. See our latest analysis for Abacus Global Management. The ABX share price has climbed steadily to $10.59, with a 30 day share price return of 6.86% and a year to date share price return of 33.71%. The 1 year total shareholder return of 104.40% points to strong momentum around...

Abacus Global Management’s subsidiary Abacus Asset Management has launched the ABX Longevity Growth and Income Fund (ABXGX), a newly effective, registered closed-end interval fund that commits 80% of its assets to longevity-related investments such as mortality contracts and other longevity-linked instruments. This marks the first registered interval fund focused on the longevity asset class, broadening access to a niche area previously dominated by private investment structures while...

The mean of analysts' price targets for Abacus Global Management, Inc. (ABX) points to a 41.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Here is how Abacus Global Management, Inc. (ABX) and Goldman Sachs (GS) have performed compared to their sector so far this year.